INTRODUCTION
transplanted islets are known to be compromised as the result of a transiently interrupted blood supply, resulting in the need for a considerably greater islet mass to be Pancreatic islets of Langerhans are richly vascularized endocrine organs. Despite the fact that islet trans-transplanted than is physiologically necessary (8, 28, 29) . It is well know that early after transplantation, even in plantation, used for the treatment of diabetes mellitus, has progressed significantly over the past few years, this cases where the immune barrier is not a concern, a substantial proportion of the islet mass will be lost, and in technique is still hampered by the limited number of donor organs (5, [35] [36] [37] . In addition to immunological bar-particular insulin-secreting beta cells (16, 36) . Several studies have revealed that this is related to suboptimal riers, the implantation and physiological function of 622 MATHE ET AL. vascularization of the graft in the early days following we have explored this possibility by using a beta cell line genetically engineered to secrete VEGF, the biolog-transplantation. The success of cell-based therapy for the treatment of diabetes, using either beta cell lines or stem ical activity of which was confirmed in a three-dimensional collagen gel coculture system with endothelial cells, which are induced to differentiate in vitro, is also likely to be compromised by the lack of an adequate cells.
It has recently been shown that adenoviral infection blood supply during the first days following transplantation (7) . of mouse islets with human VEGF enhances islet revascularization and improves function after transplantation The islet microvasculature consists of an extensive network of fenestrated capillaries. Following isolation, (46) . However, overproduction of VEGF has been associated with excessive vascular proliferation, which in islet vascular channels become devoid of an endothelial lining (22) . This reduces beta cell survival and leads to turn could promote uncontrolled angiogenesis and possibly tumor formation (39, 40) . In order to achieve con-impaired hormone secretion (23) . The molecular mechanisms that regulate islet revascularization are only be-trolled, reversible VEGF expression, we used lentiviral delivery of murine VEGF164 to the CDM3D mouse ginning to be understood, and it has been suggested that angiogenic factors are important in this process (20,23, beta cell line, which allows for tetracycline (TC)-regulated local secretion of VEGF and cell proliferation after 24, 31, 32) . Vascular endothelial growth factor-A (VEGF-A), one of the best characterized angiogenic factors (18) , transplantation. We investigated the effects of this shortterm, controlled expression of VEGF and proliferation is upregulated in response to hypoxia and hypoglycemia in many cell types, and elevated levels of VEGF have on revascularization and function of beta cells after transplantation. been found in ischemic tissues (42) . In islets, VEGF is expressed by beta cells, and synthesis can be moderately MATERIALS AND METHODS upregulated by hypoxia (43). Interestingly, we have pre-Cells viously shown that VEGF expression is increased in devascularized islets in vitro, suggesting that islets upregu-CDM3D cells are conditionally immortalized mouse late angiogenic factors spontaneously when deprived of beta cells, which have been engineered to overexpress an adequate blood supply (18) .
human bcl-2. They were derived from the βTC-tet cell In cultured islet cell lines derived from insulinomas, line, originally isolated by Dr. S. Efrat (Albert Einstein VEGF expression varies widely, being more abundant college, NY) (14) . The cells were cultivated in Dulbecin RINm5F-2A and INS-1 cells than in MIN-6 cells.
co's modified Eagle's medium (DMEM, Life Technolo-Surprisingly, none of these cell lines appear to upregugies Inc.), 15% fetal calf serum, 2.5% horse serum, 10 late VEGF under conditions of hypoxia in vitro (18) . mmol/L HEPES, 1 mmol/l sodium pyruvate, and 2 RIN-conditioned medium possessed angiogenic activity mmol/L glutamine as previously described (28) . Tetrathat was revealed to be immunologically related to cycline (TC) (Fluka) was used at 1 µg/ml in regular VEGF (18) . VEGF, which is constitutively secreted by βTC-tet cell medium. Clonally derived bovine microvasbeta cells, serves as a survival factor for existing blood cular endothelial (BME) cells from the adrenal cortex vessels, and probably also maintains vascular permeabil- (17) were provided by Drs. M. B. Furie and S. C. Silverity in order to allow optimal access of secreted hormones stein (Columbia University, NY). BME cell stock culto the systemic circulation.
tures were grown in 1.5% gelatin-coated tissue culture When purified beta cells were grafted on their own, flasks (Falcon, Beckton Dickinson Labware, Franklin endothelium was only detected within the graft after 2 Lanes, NJ) in minimal essential medium, α-modification weeks, and a large number of newly formed microves-(α-MEM, Gibco BRL Life Technologies, Paisley, Scotsels appeared to be nonfunctional (2,30). Interestingly, land), 15% donor calf serum (DCS, Gibco), and antibiif pseudo-islets, comprised of both beta and non-beta otics. cells, are transplanted, more rapid vascularization is ob-Lentiviral Infection of CDM3D Cells served (30) . Similarly, pituitary cotransplantation has been shown to increase vascularization and to improve
The mouse cDNA for VEGF-164 was kindly provided by Dr. W. Risau (Max-Planck-Institut für Psychia-insulin content in an islet allograft model (11). In both cases, there was strong evidence that the cotransferred trie, Martinsried, FRG). It was subcloned, using unique Xho-I and Not-I sites, into a modified SIN-18-phospho-tissues secreted additional angiogenic factors to those produced by beta cells. The promising results obtained glycerate kinase-woodchuck hepatitis virus vector (SIN-18-PGK-WHV) that contains a neomycin resistance following cotransplantation experiments with islets provides strong evidence that improved islet survival may gene downstream of an internal ribosome entry site from encephalomyocarditis virus (12,47). The tetracycline-in-be achieved by supplementing islet preparations with specific growth factors in lieu of cografted tissues. Here ducible VEGF viral vector was constructed as follows:
the plasmid pUHD-13-3 (kindly provided by Dr. H. Bu-lagen I (at approximately 1.5 mg/ml) were mixed with 1 volume of 10× minimal essential medium (MEM) and jard, ZMBH centrum fur Molecular Biology, Heidelberg), containing the minimal hCMV-tetn promoter, was 1 volume of sodium bicarbonate (11.76 mg/ml) on ice. This mixture was quickly dispensed into tissue culture digested with EcoRI. The mVEGF-164 cDNA was cloned into pUHD-13-3 using EcoRI sites. The minimal-wells and allowed to gel at 37°C for 10 min.
In control cultures ( Fig. 2A) , BME cells were seeded hCMV-tetop and mVEGF164 cDNA expression cassette was substituted for the PGK promoter in the SIN-18-onto 500-µl collagen gels at 100,000 cells/well in 500 µl of α-MEM (endothelial cell medium)/DMEM (βTC-PGK-WHV viral vector. High titer viral stocks were prepared as described previously using the VSV-G enve-tet cell medium) at a ratio of 1:1 together with 5% DCS. After 3 days, at which stage the BME cells had reached lope (13). Stock titers were determined by p24 enzymelinked immunosorbent assay (ELISA; NEN Life Science confluence, medium was changed, and the cells were Products Inc., Boston, MA) according to the manufacturer's instructions. CDM3D cells were infected with a multiplicity of infections ranging from 10 to 20. Selection of the pool of infected cells was initiated 48 h after infection by adding 800 µg/ml of G418 for 1 week followed by 400 µg/ml of the drug for an additional week. Cells infected with the PGK-VEGF lentivirus were named CDM3D-PGK and cells infected with the tet-op-VEGF lentivirus were named CDM3D-TET ( Fig. 1 ).
Measurement of VEGF Secretion
CDM3D, CDM3D-PGK, and CDM3D-TET cells were plated into 12-well plates at a density of 100,000 cells/well. The following day, the cells were incubated in 1 ml fresh medium (DMEM, 15% HS, 2.5% FCS) for a 6-h release period. After this initial pulse, cells were incubated for 48 h in the presence of TC (1 µg/ml) and were pulsed a second time over a period of 6 h in TCcontaining medium. VEGF secreted into the culture medium was measured using an ELISA-kit for mouse VEGF (R&D Systems, Minneapolis, MN, USA). Roskilde, Denmark) as previously described (28) . Eight a second, cell-free gel, containing a monolayer of BME cells on its upper surface. volumes of a cold solution of rat tail tendon-derived col- treated with recombinant human VEGF (165 amino acid primers were as follows: forward 5′-AGCTTGGCTCA CAGGCAA; reverse 5′-TGGCCCGTTAACGGTCCG isoform) (PeproTech Inc., Rocky Hill, NJ) or with recombinant mouse VEGF (164 amino acid isoform) TAGG. For VEGFR-3, degenerate primers were used as follows: forward 5′-CGCGAATTCGGTACAGCTCT (R&D Systems Europe Ltd., Abingdon, UK). Medium and cytokines were renewed after 2-3 days, and cultures CAGAGCTSMGARGAR; reverse 3′-CGCGGATCCT CTAGGGGCCGYCGCCGCCTNCCYTG. PCR cycles were fixed after a total of 5 days of treatment with VEGF.
Collagen Gel Coculture Assay
were as follows: for VEGFR-1 and VEGFR-2: 94°C 4 min (1×), 94°C 30 s, 58°C 30 s, and 72°C 30 s (30×); For cocultures ( Fig. 2B ), CDM3D, CDM3D-PGK, or CDM3D-TET cells were seeded in suspension at 10,000 for VEGFR-3: 94°C 4 min (1×), 94°C 30 s, 55°C 30 s, and 72°C 30 s (35×). The PCR products were electro-or 35,000 cells/well in a 350-µl collagen gel. This gel was overlaid with a second, 250-µl cell-free layer of col-phoresed in a 1.5% agarose gel containing ethidium bromide for VEGFR-1 and VEGFR-2 and in a 1% agarose lagen (31, 32) . BME cells were subsequently seeded on top of the second layer of collagen at 100,000 cells/well gel containing ethidium bromide for VEGFR-3 and photographed under UV light. For the three RT-PCRs, in 500 µl of α-MEM/DMEM medium at a ratio of 1:1 together with 5% DCS. Medium was renewed once after mouse lung was used as a positive control, H 2 O as a negative control, and duplicate samples from which the 2-3 days, and cultures were fixed after a total of 5 days.
In some experiments, a neutralizing antibody to recom-RT was omitted were amplified in parallel to control for DNA contamination. All of these were negative, demon-binant mouse VEGF 164 (R&D Systems Europe Ltd.) was added to the culture medium at a final concentration strating the absence of genomic contamination. For VEGF expression, total cellular RNA was iso-of 2 µg/ml.
Invasion was quantified from three randomly selected lated from CDM3D cells using a guanidinium-thiocyanate extraction protocol, and was analyzed by Northern 1.0 × 1.4-mm fields per well, by measuring the total length of all BME cells that had penetrated into the un-blot as described previously using a specific probe for mouse VEGF labeled with a random-primer labeling kit derlying gel either as single cells or in the form of cell cords (33). Results are from at least three wells per con-from Roche (Basel, Switzerland) (12). dition from at least two separate experiments.
Generation of Islet-Like Clusters and In Vitro Static Incubation In Vitro CDM3D Proliferation Assay
Cell lines were cultured in DMEM, 15% horse se-Clusters were generated by culturing 2 × 10 6 cells of each type in 15 ml DMEM (with or without 1 µg/ml TC) rum, 2.5% FCS, 1 mM sodium pyruvate, and 2 mM L-glutamine in 100-mm tissue culture dishes until 80% in nonadherent (agarose-coated) tissue culture dishes at 37°C. Clusters of 250-300 µm diameter were consis-confluent, washed in EDTA, and detached using trypsin. The cells were counted and seeded in 12-well plates in tently obtained after 48 h, with less than 5% of cells as single cells. duplicate at 5 × 10 4 cells/well. Media were changed every second day and duplicate wells were counted after Aliquots of 2 × 10 6 cells in clusters from each type (CDM3D, CDM3D-PGK, CDM3D-TET) were rinsed 10 days using a hemocytometer, before the cells became confluent. Data represent the average of six indepen-with Krebs-Ringer bicarbonate medium supplemented with 0.1% BSA and 2.8 mmol/L glucose (control KRB) dents experiments. and preincubated in 5 ml control KRB for 30 min, at Analysis of VEGF-Receptor (VEGFR) and VEGF 37°C. They were then submitted to three successive 1-h Expression in CDM3D Cell Lines incubations at 37°C: first in 5 ml fresh control KRB, then in 5 ml KRB containing 16.7 mmol/L glucose sup-For VEGFR expression, total cellular RNA (2 µg) from the three CDM3D cells lines was reverse tran-plemented with 0.25 mmol/L isobutylmethylxanthine (IBMX), and then again in 5 ml control KRB. The su-scribed in a 20-µl reaction containing 150 mM Tris, pH 7.4, 3 mM MgCl 2 , 100 nM of random primers, 10 mM pernatant was stored at −20°C until analysis by ultrasensitive mouse insulin ELISA (Mercodia, Sweden). DTT, and 3 U Superscript II at 42°C for 50 min followed by heat inactivation for 15 min at 70°C, and then Animals placed on ice. For each sample, one tenth of the final reaction volume was amplified in three parallel PCR Eight-week-old male C3HeB (C3H) mice, purchased from IFFA-CREDO (Arbresle, France), were bred in the reactions using primers for VEGFR-1, VEGFR-2, or VEGFR-3. VEGFR-1, forward and reverse primers were animal facility at the University of Geneva Medical Center. All experiments were approved by the institu-both located in the extracellular region of the receptor: forward 5′-AGCCCACCTCTCTATCCGCTGG; reverse tional Animal Care and Use Committee. The Principles of Laboratory Animal Care (NIH publication No. 85-23, 5′-GGCGCTTCCGAATCTCTACGA. For VEGFR-2, revised 1985) were followed during animal experiments.
mounted on glass slides and pretreated with neuraminidase type X (Sigma-Aldrich). Microvascular endothe-Mice were rendered diabetic by a single intraperitoneal administration of 250 mg/kg freshly reconstituted strep-lium was stained with Bandeiraea simpicifolia (BS-1; Sigma-Aldrich) lectin, as previously described (27). tozotocin (STZ, Sigma). After two consecutive nonfasting random blood glucose levels higher than 16 mmol/ Briefly, the sections were incubated with normal goat serum (NGS) (Dakopatts, Glostrup, Denmark) for 30 L, beta cell clusters were transplanted as indicated below (usually 8-10 days after STZ injection).
min at room temperature (RT). Biotinylated BS-1 was applied to the sections, which were incubated for 2 h at Transplantation of Beta Cell Clusters RT. Slides were washed in Tris-buffered saline (TBS), 3 × 5 min, and incubated with StreptABComplex (Dako-To eliminate the effects of graft rejection, a syngeneic model of islet cell transplantation was preferred, so patts) for 30 min at room temperature. After repeated washing, freshly prepared fuchsin substrate system (Da-that the islet cell grafts and the recipient mouse strains were of the same genetic origin, as previously described kopatts) was applied to the slides and developed. To exclude endogenous alkaline phosphatase activity in the (13).
Under general anesthesia induced by 1.5% isoflurane fuchsin substrate system, 1 mol/l levamisole (Sigma-Aldrich), dissolved in distilled water, was added before (Forene), CDM3D, CDM3D-PGK, or CDM3D-TET cell clusters were transplanted under the left kidney capsule development. The sections were counterstained with hematoxylin. Control slides were incubated with NGS of three groups of diabetic C3H mice (n = 5/group), using standard techniques as previously described (4).
(Dakopatts) diluted in TBS containing 0.1% bovine serum albumin (dilution 1:20) instead of BS-1. Randomly Three different groups (n = 5/group) were grafted with clusters of each cell, following in vitro treatment with chosen tissue sections ( ≥ 12), from different parts of the grafts, were evaluated in each animal. BS-1-stained en-TC (1 µg/ml) for 48 h. After transplantation, the drug was continuously administered to grafted mice via drink-dothelial cells were counted independently by two operators. Vascular density was then calculated as the num-ing water (1 mg/ml). Two additional groups of mice (n = 5/group) were transplanted with CDM3D-PGK-ber of stained endothelial cells. For beta-cell mass, 5-µm sections from three levels and CDM3D-TET-cells, and were treated with TC via drinking water only after hyperglycemia had been cor-at 20 section intervals (i.e., approximately 100 µm apart) were stained with hematoxylin and eosin. The graft area rected.
was photographed with a Nikon Coolpix 4500 mounted Graft Function on a ZEISS Axioskop 40 microscope and analyzed with a LeikaQwin image analysis software program. The sur-Daily measurement of random BG levels was performed on tail vein blood samples with Glucometer face area of the graft was measured and the mean of the three levels was calculated. Kidneys from at least three strips (MediSense, Abbott AG, Switzerland) after transplantation. Time to normoglycemia and the percentage animals were analyzed for each condition. animals achieving normoglycemia were determined for Statistical Analysis each group. The day of normoglycemia was defined as Statistical analysis was performed using the SPSS the first of three consecutive days with a random BG 10.0 program (SPSS Institute, Chicago, IL). Values are level of less than 11 mmol/L. Intraperitoneal glucose expressed as mean ± SEM or as mean ± SD, as inditolerance tests (IPGTT) were performed 6 weeks after cated. Comparisons were performed by two-tailed untransplantation, as described previously (34) . Briefly, paired Student's t-test or by one-way ANOVA. Statistimice were fasted for 16 h and glucose was injected incal significance was defined as p < 0.05. traperitoneally at a dose of 2 g/kg. BG was measured at 0, 15, 30, 60, 90, and 120 min following glucose injec-RESULTS tion. To verify that the reversal of diabetes was not due Bioactivity of VEGF Produced by Engineered to residual function of the native pancreas, unilateral ne-CDM3D Cells phrectomy of the graft-bearing kidney was also performed and BG measured.
Endothelial cells cultured on the surface of a threedimensional collagen gel grow to confluence and do not Quantification of Graft Microvascular Density invade the underlying matrix, either in the absence or and Beta Cell Mass presence of TC (Fig. 3a, b) . Treatment with recombinant human or mouse VEGF (Fig. 3c, d) or coculture with Graft-bearing kidneys were removed 6 weeks posttransplant, fixed in 10% formaldehyde, dehydrated in VEGF-secreting CDM3D cells (Fig. 3g, i) induced BME cells to invade the underlying matrix, forming a branching ethanol, and embedded in paraffin.
For microvascular density, 5-µm sections were and anastomosing network of capillary-like structures beneath the surface monolayer. Invasion was quantitated growth arrest (see later). Because growth is inhibited by TC, these data suggest that growth arrest may have con-by measuring the total additive length of all cells that had penetrated into the underlying gel, either in the form tributed to a reduction in VEGF secretion and hence a reduction in invasion. The minimal invasion that oc-of cell cords or as individual cells (Fig. 4) .
Treatment with recombinant human and mouse curred in the presence of TC could be due either to low level VEGF secretion by TC arrested cells or to remain-VEGF induced a dose-dependent invasive response (Table 1), as previously described (33). Furthermore, the ing VEGF stored in the three-dimensional collagen gel. Coculture of BME cells with CDM3D-PGK cells in-response to mouse VEGF was comparable to that seen with the human cytokine (Table 1) . BME cell invasion duced a marked invasive response that was dependent on the number of cells added (Fig. 3g , Table 2 ). Addi-in response to human or murine VEGF was not significantly affected by the addition of TC at 1 µg/ml from tion of a neutralizing antibody to mouse VEGF inhibited invasion by 92 ± 5% (Fig. 3h , Table 2 ). In the absence day 0 ( Fig. 3c, d , Table 1) . Figure 3e and f shows the behavior of BME cells of TC, coculture with CDM3D-TET cells induced a strong invasive response that was proportional to the cocultured with CDM3D cells. Minimal invasion occurred ( Fig. 3f , Table 2 ). A cell concentration-dependent number of cells added (Figs. 3i, Fig. 5 , Table 2 ). When compared to coculture with 3.5 × 10 4 CDM3D cells, induction of invasion was nonetheless observed with 10 4 and 3.5 × 10 4 CDM3D cells. At the latter concentration, BME cell invasion was fivefold higher in CDM3D-TET cocultures (Fig. 4) . Invasion was inhibited by the addi-invasion was reduced almost to basal levels by treatment with a neutralizing antibody to mouse VEGF. Similar tion of a neutralizing anti-mouse VEGF antibody ( Fig.  4 , Table 2 ). Addition of TC markedly inhibited the inva-results were obtained when the cells were grown in the presence of TC from day 0 ( Table 2) . When TC was sive response (Fig. 4) . The extent of inhibition was dependent on whether or not the cells were pretreated with added to CDM3D cells in monolayer culture for 2 days prior to coculture, invasion was reduced. We have ob-TC: pretreatment of monolayer cultures for 2 days prior to coculture resulted in a greater degree of inhibition served that VEGF transcripts, which are present in proliferating CDM3D cells, become undetectable following (81 ± 2%) than when TC was added at the time the cocultures were established (45 ± 4%) ( Fig. 3j , Table 2 ). Addition of a neutralizing antibody to mouse VEGF inhibited invasion by 53 ± 10%) ( Fig. 5 ). Invasion that occurred in the presence of TC (added on day 0 or day −2) was inhibited by almost 100% in the presence of the anti-VEGF antibody (data not shown).
In Vitro Proliferation of CDM3D Cell Lines
Cells were seeded at 5.0 × 10 4 per well and grown for 10 days. CDM3D-TET and CDM3D-PGK cells proliferated significantly faster than CDM3D control cells. Compared to CDM3D cells, which underwent approximately 8 population doublings, CDM3D-TET underwent approximately 19 population doublings (p < 0.005) and CDM3D-PGK underwent approximately 14 population doublings (p = 0.027) (Fig. 5 ). 
VEGF Expression in Proliferating Versus Growth-Arrested Cells

15-20 ng of VEGF/10 6 cells/24 h. In contrast, cells ex-
Coculture in the presence of TC from day 0 (small dots). Copressing VEGF under the control of the TC system culture in the presence of TC from day 0 plus anti-rmVEGF (CDM3D-TET cells) produced much higher levels of (small squares). Coculture in the presence of TC from day 2 (empty columns). VEGF: 1 µg VEGF/10 6 cells/24 h was detected in the The number of photographic fields analyzed for each condition (n) is shown. Results are expressed as mean and SEM. TC was present throughout the duration of the experiment, where indicated.
culture supernatant. Results are from at least three wells neither the endogenous mouse transcript nor the exogenous transcript could be detected, and levels of secreted per condition from at least two separate experiments.
Because growth-arrested CDM3D cells expressed immunoreactive VEGF were downregulated as much as 40-fold, with CDM3D-TET cells producing 25-30 ng minimal invasion-inducing activity, we decided to compare basal levels of VEGF mRNA expression in growth-VEGF/10 6 cells/24 h. arrested versus proliferating cells. In proliferating VEGF-Receptor Expression in CDM3D Cell Lines CDM3D, CDM3D-PGK, or CDM3D-TET cells, a band corresponding to the expected size of the endogenous Given the fact that CDM3D cells that overexpress VEGF proliferate more rapidly than the parental cell mouse VEGF transcript was detected (Fig. 6A) . In proliferating CDM3D-PGK cells, additional transcripts line, we thought it important to determine whether the cells express VEGF receptors. VEGFR-1 and VEGFR-2 could not be detected, suggesting that VEGF is poorly expressed in these cells. This is in agreement with secre-(but not VEGFR-3) were expressed by all three cell lines (Fig. 6B ). This is in keeping with our previous observa-tion data, which showed a minimal increase in VEGF compared to CDM3D cells (see above). In proliferating tion that immortalized beta cell lines express VEGFRs (16) . Therefore, because the potential exists for an auto-CDM3D-TET cells, an additional band was detected, which corresponds to the size of the expected transcript crine effect of VEGF on CDM3D proliferation, we assessed the effect of VEGFR tyrosine kinase inhibitors as originating from the viral vector (3.8 kb). Following growth arrest of these cells (treated with TC for 3 days), well as blocking VEGFR-1 and VEGFR-2 antibodies on The number of photographic fields analyzed for each condition (n) is shown. Results are expressed as mean and SEM. TC (1 µg/ml) was present throughout the duration of the experiment where indicated. A neutralizing antibody to mouse VEGF was used at 2 µg/ml and introduced at day 0. In some experiments, beta cells were treated for 2 days with TC (day −2) before establishing the cocultures.
moglycemia after 17 and 20 days, respectively, while 100% of mice returned to normoglycemia after 22 and 24 days, respectively. The difference was statistically significant (p < 0.05) (Fig. 8A) . Results obtained with IPGTT performed at 28 days are shown in Figure 8B . While glycemia remained elevated for up to 2 h after glucose injection in mice transplanted with CDM3D cell clusters, a significant decrease in blood glucose was observed 15, 30, 60, 90, and 120 min after glucose injection with CDM3D-PGK and CDM3D-TET cell clusters. Thus, the clearance of plasma glucose after intraperitoneal injection was accelerated in the CDM3D-PGK and CDM3D-TET groups. from the day of transplantation. The drug was expected to induce growth arrest in all three cell types and to reduce VEGF secretion of CDM3D-TET cells. None of proliferation. Despite many attempts under a variety of experimental conditions, consistent inhibition of prolif-the TC-treated diabetic mice returned to normoglycemia ( Fig. 9A) and no response was observed following glu-eration was not observed (data not shown). We therefore were unable to attribute the increased growth rate of cose administration in IPGTTs evaluated 28 days after transplantation (Fig. 9B ). TC was also administered (1 CDM3D-PGK and CDM3D-TET cells to an autocrine effect of VEGF. The reasons for the observed increase mg/ml) to the drinking water of mice grafted with CDM3D-PGK and CDM3D-TET clusters only after nor-in proliferation are not known. moglycemia had been achieved. Under these conditions, In Vitro Glucose-Stimulated Insulin Response graft function was maintained as evidenced by the maintenance of normoglycemia throughout the remaining The secretion of insulin by CDM3D, CDM3D-PGK, and CDM3D-TET cell clusters in vitro at a glucose con-study period (Fig. 9C ). To verify that the reversal of diabetes was not due to restitution of the function of the centration of 2.8 mmol/L was virtually identical (Fig.  7) . Glucose (16.7 mmol/L) supplemented with IBMX native pancreas, nephrectomy was performed on the graft-bearing kidney. All animals became diabetic within induced a twofold increase in insulin secretion by all three cell types (Fig. 7) . This indicates that viral trans-24 h of the procedure (Fig. 9C ). fection does not significantly influence basal or glucose-
Effect of Tetracycline-Induced Growth Arrest and Inhibition of VEGF Secretion
Quantification of Graft Vascular Density and Beta Cell stimulated insulin secretion levels in CDM3D cell clus-Mass 6 Weeks Posttransplant ters in vitro.
With regard to intragraft vascular density, the density Graft Function After Transplantation of BS-1-stained cells was significantly greater in grafts of CDM3D-PGK and CDM3D-TET cells when com-To assess the role of VEGF overexpression on glycemic control by transplanted CDM3D cell clusters, res-pared to CDM3D grafts (Fig. 10A, B ). There was no significant difference in vascular density in grafted TC-toration of normoglycemia and dynamic changes in blood glucose concentrations were evaluated. When treated CDM3D-PGK and CDM3D-TET cell clusters when compared to CDM3D grafts (Fig. 10B ). clusters of CDM3D cells were transplanted, 50% of mice returned to normoglycemia after 30 days and 100%
Mice transplanted with CDM3D-PGK and CDM3D-TET cells had a significantly increased (p < 0.001 and after 38 days. When clusters of CDM3D-PGK or CDM3D-TET cells were used, the time to achieve norp < 0.05, respectively) beta cell mass when compared with control CDM3D cell grafts. Mice treated with TC moglycemia was reduced: 50% of mice returned to nor-Figure 6. VEGF and VEGFR expression by CDM3D cells. (A) Northern blot analysis of mouse VEGF mRNA expression in CDM3D cells transduced with lentiviral vectors. Total cellular RNA extracted from proliferating or growth-arrested cells (3 days in TC) was analyzed using a randomprimed probe generated from mouse VEGF cDNA. In all cases, growth arrest dramatically decreased VEGF expression. As shown previously, murine beta cells derived from pancreatic tumors express VEGF; however, upon growth arrest, transcription of endogenous VEGF is arrested in CDM3D cells. Ethidium bromide staining of the gel shows equal loading of total RNA in each condition. (B) RT-PCR for VEGFRs. RNA was extracted from confluent tissue culture dishes of CDM3D, CDM3D-TET, or CDM3D-PGK cells and was reverse transcribed (RT). The products were amplified by PCR with specific primers for VEGFR-1, VEGFR-2, or VEGFR-3. Bands corresponding to the expected size of VEGFR-1 and VEGFR-2 are present in all three cell lines. PCR performed with specific primers for VEGFR-3 showed no band in any of the three cell lines; however, mouse lung (which was used as a positive control) gave a band of the expected size. H 2 O was used as a negative control and duplicate samples from which RT was omitted were amplified in parallel to control for DNA contamination; all of these were negative showing the absence of genomic contamination.
to be a contributing factor to the impaired revascularization (30) . It has been also shown recently that adenovirus-based VEGF gene delivery to mouse and human islets enhances islet revascularization and improves function after transplantation (9,46). However, overproduction of VEGF has been associated with excessive vascular proliferation, which in turn promotes uncontrolled angiogenesis and possibly tumor formation (39, 40) .
The aim of this study was to establish in vitro and in vivo systems that can be used to regulate and monitor angiogenesis induced by transplanted beta cells, with the Figure 7 . Glucose-stimulated insulin release from clusters of CDM3D, CDM3D-PGK, or CDM3D-TET cells. Cells (2 × 10 6 of each type in clusters were sequentially incubated for 1 h at 37°C under low (2.8 mmol/L) glucose conditions, switched to high (16.7 mmol/L) glucose supplemented with 0.25 mmol/L isobutylmethylxanthine (IBMX), followed by return to low (2.8 mmol/L) glucose concentrations. All samples were assayed in triplicate, and the experiment was repeated three times. Results are shown as mean ± SD from the three experiments (i.e., n = 9 samples per column). via drinking water for 6 weeks and grafted with TCtreated cells had a significantly reduced beta cell mass when compared to nontreated mice transplanted with the same cell lines (p < 0.001 for all three cell lines). Mice injected with nontreated CDM3D-PGK and CDM3D-TET cells and treated with TC via drinking water after having returned to normoglycemia had a significantly increased beta cell mass (p < 0.001 and p < 0.01, respectively) when compared to mice that had received the same cell lines and did not receive TC (Fig. 11) .
DISCUSSION
It is now well documented that the revascularization process is critical for the success of beta cell transplantation, particularly because isolated islets or beta cells, un- (25, 30, 41, 45) . Central islet necrosis as well as the loss cemia after transplantation. CDM3D, CDM3D-PGK, or CDM3D-TET cell clusters (2 × 10 6 ) were transplanted under of graft insulin content has been well documented folthe kidney capsule of streptozotocin (STZ)-induced diabetic lowing transplantation, and both phenomena have been syngeneic mice without TC treatment (n = 10/group). Norstrongly correlated to the ischemic status of the graft, moglycemia was achieved more rapidly in mice transplanted which is principally the consequence of a lack of early with CDM3D-PGK or CDM3D-TET than CDM3D cell clusrevascularization (11, 25, 45) . Several studies have demters *p < 0.001 (Mann-Whitney Test). (B) Intraperitoneal glucose tolerance test 28 days after transplantation. (n = 5/group). onstrated that islets can moderately upregulate VEGF Mice that had been fasted for 16 h were injected with 2 g/kg under conditions of hypoxia in vitro and in the early glucose intraperitoneally, with blood glucose measured from phase following transplantation in vivo (18, 43) . Howsnipped tails at 0, 15, 30, 60, 90, and 120 min. The data are ever, VEGF expression is significantly decreased in presented as mean blood glucose ± SD. *p < 0.01 in mice transplanted islets in the presence of hyperglycemia transplanted with CDM3D-PGK or CDM3D-TET versus CDM3D cell clusters.
(6,21,26). This attenuated VEGF expression is thought aim of being able to optimize angiogenesis-enhancing number of gene therapy studies and is as powerful at inducing angiogenesis as the two other major isoforms strategies for improving islet cell survival following transplantation. VEGF remains an attractive candidate (121 and 188 amino acids) (42) . It has also been used in encapsulated cell therapy using genetically engineered for inducing new blood vessel formation, despite the fact that it has been shown to have some deleterious effects primary myoblasts, where it has been shown to be a potent angiogenic factor (40) . We have used genetically if delivered in excess (38) (39) (40) . The 164 amino acid isoform of VEGF used in this study has been shown to be modified CDM3D beta cells by taking advantage of their unique conditional immortalization. Using a lentiv-present in islets (44) . This isoform has been used in a Quantification of graft beta cell mass 6 weeks after transplantation. Grafts of CDM3D-PGK and CDM3D-TET cells were increased in size when compared to CDM3D cell grafts (*p < 0.001 and p < 0.05). TC-treated mice transplanted with TC-treated cells had a reduced graft mass when compared to nontreated mice (**p < 0.001, p < 0.001, and p < 0.001). Mice transplanted with non-TC-treated CDM3D-PGK and CDM3D-TET cells and treated with TC only when hyperglycemia was corrected had an increased graft mass relative to CDM3D cell grafts (***p < 0.001 and p < 0.01).
irus-based approach that has been shown to transduce proliferation by TC was clearly also critical, particularly because proliferation of the VEGF transgenic cells was and induce stable gene expression in both islets and postmitotic beta cells (12,13,19), we have shown that greater than that of standard CDM3D cells. Proliferation of the CDM3D cell line is strictly con-potent and regulated delivery of VEGF can be achieved, and that we can increase the capacity of these cells to trolled by the large-T/small-t antigen expression unit under the control of a TC-regulated promoter: expression induce neovascularization in vitro. In vivo, time to normoglycemia, IPGTT, graft vascular density, and cellular occurs in the absence of TC, and this results in cell proliferation. In the presence of TC, expression of the SV40 mass were evaluated following transplantation of genetically engineered CDM3D cells into syngeneic mice. In-antigens is shut off and the cells stop proliferating. The characteristics of the βTC-tet cell line (from which creased expression of VEGF resulted in a significant increase in vascular density in grafted TET and PGK cells CDM3D cells are derived) following TC withdrawal have been described in detail, and have emphasized their versus control cells, and this was associated with an increase in graft cellular mass. The time required for dia-unique, fully differentiated phenotype (15) . Most tumor cell lines derived from pancreatic insulinomas express betic mice to return to normoglycemia and stimulated plasma glucose clearance was also significantly acceler-significantly higher level of VEGF than CDM3D cells. They are also less well differentiated, and grow much ated in mice transplanted with TET and PGK cells when compared to control cells.
faster. Expression of endogenous VEGF in the CDM3D cells lines appears to be proliferation dependent. We The most significant finding in this study is that our approach enabled drug-controlled, reversible VEGF ex-have also observed that both endogenous and exogenous VEGF transcripts become undetectable following growth pression after CDM3D cell cluster transplantation. The addition of TC to the system also allowed us to inhibit arrest of CDM3D-PGK and CDM3D-TET cells. We are unable to determine the relative contribution of TC-proliferation of the transplanted cells. VEGF secretion and cell proliferation were only required during the early controlled (a) growth arrest and (b) regulation of VEGF expression in these cells. The ideal control would have posttransplantation period; when subsequently inhibited by the addition of TC, normoglycemia and graft vascu-been the CDM3D-PGK line, in which VEGF secretion per se is not regulated be TC. However, exogenous larization were maintained. TC-treated mice grafted with TC-treated cells failed to restore normoglycemia. This VEGF transcripts are not detectable in CDM3D-PGK cells, and basal levels of secretion are relatively low. system thus allowed us to turn off VEGF expression once the desired effect had been achieved. Inhibition of With respect to the increase in proliferation observed
